MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12871-026-04054-w

Медицинская библиотека · BMC anesthesiology · 2026

Effect of hepatic arterial dexamethasone administration on long-term survival among hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization.

Yan Fang, Wang Yan, Huang Yang, Xing Wei, Guo Ying

СтатьяПеревод в очереди

Аннотация

BACKGROUND

In cancer patients, dexamethasone has been linked to long-term survival outcomes, but there is uncertainty as to its effect on survival outcomes among patients with hepatocellular carcinoma (HCC) who undergo transcatheter arterial chemoembolization (TACE).

METHODS

We retrospectively reviewed HCC patients who underwent TACE as the initial treatment between January 2014 and December 2016. Patients were categorized into the dexamethasone group and no dexamethasone group. We conducted propensity score matching (PSM), inverse probability weighting (IPTW) and adjusted for propensity score. Our endpoints were progression-free survival (PFS) and overall survival (OS). We also performed exploratory analyses in subgroups to assess the association between hepatic arterial dexamethasone and survival outcomes in pre-specified subgroups.

RESULTS

Hepatic arterial dexamethasone was correlated with a favorable long-term survival in unadjusted and multivariate analysis. IPTW showed patients receiving hepatic arterial dexamethasone had prolonged PFS (HR = 0.69, 95%CI 0.49-0.95, P = 0.024) and OS (HR = 0.72, 95%CI 0.52-1.00, P = 0.047). Similar trends were observed in PSM and another propensity score analysis. Survival benefit of hepatic arterial dexamethasone remained in the subgroup undergoing platinum-based TACE.

CONCLUSION

Hepatic arterial dexamethasone might be associated with better long-term survival in HCC patients undergoing TACE. This study highlights the clinical significance of hepatic arterial dexamethasone in HCC patients undergoing TACE.

Для цитирования: Yan Fang, Wang Yan, Huang Yang, Xing Wei, Guo Ying. Effect of hepatic arterial dexamethasone administration on long-term survival among hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization.. BMC anesthesiology. 2026. DOI: 10.1186/s12871-026-04054-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.